It’s been pointed out that the Orioles acquired Russ Canzler the same day that Danny Valencia was named in a story about performance-enhancing drugs.
Valencia has vehemently denied involvement with Biogenesis, and says he has never used PEDs nor failed a drug test. Let’s hope it’s true.
Canzler and Valencia are essentially competing for the same position on the roster. Dan Duquette, the Orioles executive vice president for baseball operations likes that Canzler hits left-handed pitching well. He said the same thing when he picked up Valencia back in November.
Valencia is a third baseman, but if Manny Machado plays well, there’s no room for him there. He could get a turn at designated hitter. So could Canzler, who’s a first baseman.
The first base/designated hitter role is murky. The assumption is that Chris Davis enters spring training as the team’s first baseman even though he didn’t play much there after May. With Mark Reynolds’ departure and the Orioles’ not picking up a big name first baseman, signs point to Davis playing first.
Manager Buck Showalter has said he’d like Davis as his regular first baseman and even said one of the reasons he went through painful partial knee replacement surgery was to work with him in spring training.
While Canzler isn’t known as a first baseman; he’s played a few more major league games in left field than at first, one of Duquette’s earlier acquisitions is.
Are Canzler and Valencia competing for one spot?
CSN Baltimore | Feb 6